Janssen Receives Positive CHMP Opinion Recommending Expanded Use of Imbruvica in Two Indications in Europe
BEERSE, Belgium–(BUSINESS WIRE)–The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human…